Abstract 4564: Tumor infiltrating lymphocytes are associated with p16 protein expression in acral lentiginous melanoma
Marco Gálvez-Niño(Instituto Nacional de Enfermedades Neoplásicas), Henry Gómez(National Cancer Center), Luis A. Bernabe(Instituto Nacional de Enfermedades Neoplásicas), Carlos A. Castañeda(Syracuse University), Miluska Castillo(Instituto Nacional de Enfermedades Neoplásicas), Valeria Villegas(Universidad Peruana Cayetano Heredia), Julio Abugatas(Instituto Nacional de Enfermedades Neoplásicas), Joselyn Sanchez(Instituto Nacional de Enfermedades Neoplásicas), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Jorge Dunstan(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
|Journal of Clinical Oncology|2007|483
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
|npj Breast Cancer|2021|282